Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Randomized Experiments01:13

Randomized Experiments

7.2K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
7.2K
Chi-square Analysis02:46

Chi-square Analysis

38.7K
The chi-square test is a statistical hypothesis test. It is used to check whether there is a significant difference between an expected value and an observed value. In the context of genetics, it enables us to either accept or reject a hypothesis, based on how much the observed values deviate from the expected values.
The chi-square test was developed by Pearson in 1990.
The first step of performing a Chi-square analysis is to establish a null hypothesis, which assumes that there is no real...
38.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor visualization and evaluation of glioblastoma in mice using small animal 9.4T MRI and PET‑CT with high resolution.

Oncology reports·2026
Same author

Corrigendum to "TMEM176A drives anti-apoptotic signaling through TGM2-mediated ERK activation in gastric cancer" [Int. Immunopharmacol. 168 (2026) 115798].

International immunopharmacology·2025
Same author

TMEM176A drives anti-apoptotic signaling through TGM2-mediated ERK activation in gastric cancer.

International immunopharmacology·2025
Same author

P2RX4 promotes hepatocellular carcinoma progression via calcium-mediated PI3K/AKT activation and immune remodeling.

World journal of surgical oncology·2025
Same author

BCL-2 Inhibitor Regulates Number, Function, and Antitumor Immunity of T Cells by Influencing Glycolysis in AML.

Cancer science·2025
Same author

Alterations in serum exosomal miR-1207-5p levels reflect severity and progression risk in type 2 diabetic kidney disease.

BMC nephrology·2025

Related Experiment Video

Updated: Sep 10, 2025

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

401

Cholecystitis and cholangiocarcinoma: a two-sample Mendelian randomization study.

Xing Gao1,2, Hao Gao3, Song Wang4

  • 1Gansu Province Key Laboratory of Environmental Oncology, The Second Clinical Medical College of Lanzhou University, Lanzhou, 730000, Gansu, China.

BMC Gastroenterology
|August 26, 2025
PubMed
Summary

Cholecystitis, or gallbladder inflammation, may causally increase the risk of cholangiocarcinoma (bile duct cancer). This Mendelian Randomization study suggests gallbladder disease management could potentially lower bile duct cancer risk.

Keywords:
CholangiocarcinomaCholecystitisMendelian randomization analysis

More Related Videos

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

52.8K
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

15.8K

Related Experiment Videos

Last Updated: Sep 10, 2025

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

401
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

52.8K
Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis
04:38

Partial Bile Duct Ligation in the Mouse: A Controlled Model of Localized Obstructive Cholestasis

Published on: March 28, 2018

15.8K

Area of Science:

  • Hepatobiliary medicine
  • Gastroenterology
  • Cancer epidemiology

Background:

  • Global cholangiocarcinoma (bile duct cancer) incidence is rising, particularly intrahepatic cholangiocarcinoma.
  • Epidemiological studies suggest a link between cholecystitis (gallbladder inflammation) and increased risk of hepatobiliary cancers.
  • Observational studies have limitations in establishing causality due to confounding factors.

Purpose of the Study:

  • To investigate if cholecystitis is an independent causal risk factor for cholangiocarcinoma.
  • To utilize Mendelian Randomization (MR) to overcome limitations of observational studies.

Main Methods:

  • Employed Mendelian Randomization (MR) using 25 single nucleotide polymorphisms (SNPs) as instrumental variables for cholecystitis.
  • Utilized a large genome-wide association studies (GWAS) dataset from the Integrative Epidemiology Unit (IEU) for cholangiocarcinoma outcome data.
  • Applied five MR statistical techniques and conducted sensitivity analyses including MR Egger intercept, leave-one-out, and funnel plots.

Main Results:

  • The Inverse Variance Weighted (IVW) method indicated a significant association between genetically predicted cholecystitis and increased cholangiocarcinoma risk (OR=2.915, P=0.038).
  • The Weighted Median Method supported this finding (P=0.016).
  • Sensitivity analyses (MR Egger, Simple Mode, Weighted Mode) and pleiotropy tests showed no significant confounding effects.

Conclusions:

  • Evidence supports a causal relationship between cholecystitis and cholangiocarcinoma.
  • Patients with cholecystitis may have an elevated risk of developing cholangiocarcinoma.
  • Findings may guide clinical strategies for cholecystitis management to potentially reduce cholangiocarcinoma incidence.